Movicol Sans Arome (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that remains largely unabsorbed in the gut. It creates an osmotic gradient that draws water into the intestinal lumen, increasing stool volume and softness. The added electrolytes help maintain fluid balance, allowing peristalsis to move the softened stool more effectively.

The dose of Movicol Sans Arome is individualized by the prescribing healthcare professional based on the patient’s age, weight, severity of constipation and clinical response. The prescriber determines the appropriate volume of the oral solution and any necessary adjustments.

Safety data for Movicol Sans Arome during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Movicol Sans Arome. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative class is other osmotic laxatives such as lactulose. Compared with lactulose, Macrogol‑based solutions like Movicol Sans Arome generally cause fewer gas‑related side effects and provide a more predictable osmotic effect, making them preferred for patients who need rapid and reliable stool softening.

Movicol Sans Arome should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from moisture, direct sunlight and extreme temperatures. Keep the bottle tightly closed when not in use to maintain product stability.

The product is supplied as a clear oral solution. It is typically mixed with a measured amount of water or another clear fluid as directed by the prescriber, then taken by mouth. The solution should be consumed promptly after preparation and any unused portion discarded according to local regulations.

Serious risks include severe electrolyte imbalance (especially sodium or potassium disturbances), dehydration, and allergic reactions that may manifest as rash, swelling or breathing difficulty. Patients should be monitored for signs of these conditions, and medical attention sought immediately if they occur.

The product should be avoided in individuals with known hypersensitivity to any component, in patients with intestinal obstruction or severe renal impairment, and in those for whom electrolyte disturbances could be hazardous. A healthcare professional should evaluate suitability before initiating therapy.